Sagittarius Life Science

Sagittarius Life Science FCF per Share

The Free Cash Flow per Share of Sagittarius Life Science (3205.TWO) as of Oct 31, 2026 is -0.54 TWD. In the previous year, Free Cash Flow per Share was -1.47 TWD — a change of -63.40% (higher).

FCF per Share

-0.54TWD

YoY

-63.40%

Last updated:

Free Cash Flow per Share of Sagittarius Life Science is 2025 -0.54 TWD. Free Cash Flow per Share of Sagittarius Life Science was 2024 -1.47 TWD. It decreases by -63.40% higher compared to the previous year.

The Sagittarius Life Science FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-1.77 TWD
Jan 1, 2019
-3.64 TWD
Jan 1, 2020
-2.26 TWD
Jan 1, 2021
-1.16 TWD
Jan 1, 2022
-1.66 TWD
Jan 1, 2023
-2.21 TWD
Jan 1, 2024
-1.47 TWD
Jan 1, 2025
-0.54 TWD
The Sagittarius Life Science FCF per Share history
YEARFCF per ShareYoY
-0.54TWD-63.40%
-1.47TWD-33.15%
-2.21TWD+32.98%
-1.66TWD+43.53%
-1.16TWD-48.79%
-2.26TWD-37.95%
-3.64TWD+105.63%
-1.77TWD+121.08%
-0.80TWD-106.17%
12.97TWD+44.95%
8.95TWD+331.06%
2.08TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sagittarius Life Science Stock analysis

What does Sagittarius Life Science do? Sagittarius Life Science Corp. generates revenue through the manufacture and sale of Chinese and western medicine, including nutrition and health formulations, natural and organic food, beverages, probiotic fermentation products, beauty care ingredients, Chinese herbal medicines, plant new medicines, and health supplies. The company serves domestic markets in Taiwan and overseas markets in Asia and the Americas, distributing its products through established channels. Technical services for pharmaceutical R&D are also a key revenue stream, supporting clients in developing both traditional and modern medicine solutions. The firm's product portfolio targets health-conscious consumers seeking natural and organic solutions, as well as businesses in the pharmaceutical and beauty care industries requiring specialized ingredients and formulations. Domestic sales focus on Taiwan, while international distribution extends to Asian regions outside of Taiwan and the Americas, reflecting a strategic market expansion. Revenue is derived from direct product sales and technical service contracts, with no mention of third-party partnerships or additional revenue streams beyond the described offerings. Sagittarius Life Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sagittarius Life Science stock

Free Cash Flow per Share of Sagittarius Life Science is -0.54 TWD in 2025.

Free Cash Flow per Share of Sagittarius Life Science changed from -1.47 TWD to -0.54 TWD, representing a -63.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Sagittarius Life Science since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Sagittarius Life Science

All Key Metrics — Sagittarius Life Science